In this issue

Cell Cycle
Volume 12, Issue 10
May 15, 2013
View current issue
About the cover
Cdc7 kinase coordinates S-phase events by promoting the activation of replica tion origins and mediating responses to replication fork stalling. ...
Continue reading

Congratulations to Sir John B. Gurdon and
Shinya Yamanaka, the 2012 recipients of the
Nobel Prize in Physiology or Medicine "for the discovery that mature cells can be reprogrammed
to become pluripotent."

Most Popular Downloads

15 Jan 13
PI3K-Akt pathway regulates polycomb group protein and stem cell maintenance
Yan Liu, Hao Yu and Stephen D. Nimer
15 May 13
Cell cycle checkpoint regulators reach a zillion
Kimberly M. Yasutis and Keith G. Kozminski
15 May 13
Genetic and physical interactions between the yeast ELG1 gene and orthologs of the Fanconi anemia pathway
Shivani Singh, Keren Shemesh, Batia Liefshitz, et al.

Upcoming Meetings

Frontiers of NMR in Biology- Keystone Symposium
January 13-18, 2013
Snowbird, Utah

Mammalian DNA Repair- Gordon Research Conference
February 10 - 15, 2013
Ventura, California

Autophagy, Inflammation and Immunity- Keystone Symposium
February 17 - 22, 2013 
Montreal, QC, Canada


Landes Highlights

Relevant articles recently published in other Landes journals

Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest. Coon et al. Cell Cycle 11(4); Feb 15, 2012.

EDD induces cell cycle arrest by increasing p53 levels. Veronique A.J. Smits. Cell Cycle 11(4); Feb 15, 2012.

 

Editor-in-Chief

M.V. Blagosklonny, M.D., Ph.D.
Roswell Park Cancer Institute
Buffalo, NY
Email the Managing Editor, Tara Barton.
Print ISSN: 1538-4101
Online ISSN: 1551-4005
IF: 2011 - 5.359
http://dx.doi.org/10.4161/cc
Abstracted/Indexed In:
Medline/PubMed, Science Citation Index Expanded (Web of Science), Scopus

Open Access in Cell Cycle

Cell Cycle offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.

The cost to make an original research paper OA is $1000.00 USD.

For reviews and brief reports, OA is $750.00 USD.

For all other types of papers, the OA fee is $500.00 USD.

In addition to the cell cycle and cell division, Cell Cycle covers all topics from man to virus, from DNA to RNA, from aging to development, from cell senescence to stem cells, from apoptosis to autophagy, from cancer to neurobiology, from molecular and theoretical biology to medicine and therapy.

Find us on Facebook

Scooped?

If your lab's work was recently scooped by a paper in Cell, Nature or Science, please contact us for ultra-rapid peer-review and publication

Submit your paper to Cell Cycle

Cell Cycle utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.

There are 3 submission tracks to choose from:

  1. General Submission
  2. Select Submission Track
  3. Expedited Submission Track

Important Journal Links

Guidelines for Authors

Submit your manuscript online

Recommend Cell Cycle to your library

Select submission track: Cell Cycle will reconsider papers rejected by Science, Nature, Cell and others.

Cell Cycle recognizes that excellent papers may have been erroneously rejected by other journals. We will reconsider papers that have been rejected by Nature, Science, Nature Medicine, Nature Cell Biology, Cell, Cancer Cell, Cell Metabolism, Developmental Cell, NEJM, Lancet, Genes & Development and some other journals in the original format of those journals, thus saving the authors effort and time. The authors are encouraged to enclose the reviewers' and/or editorial comments from the above mentioned journals. This will certainly expedite the evaluation of the article and it is possible the article might be accepted based on its previous review. This will allow the urgent and competitive research to be published in a timely manner. You may submit your paper online. Following submission, please contact Yelena Boryskina, Assitant to the Editor-in-Chief, with the manuscript number and copies of the previous reviews. If you have questions, you may also contact Dr. Blagosklonny, the Editor-in-Chief, directly.
Advertisements